Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene therapy for cancer: present status and future perspective
Magid H. Amer
Molecular and Cellular Therapies (2014) Vol. 2, Iss. 1, pp. 27-27
Open Access | Times Cited: 222

Showing 26-50 of 222 citing articles:

Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions
Murali Ragothaman, So Young Yoo
Vaccines (2023) Vol. 11, Iss. 5, pp. 919-919
Open Access | Times Cited: 25
Two‐Photon Mediated Cancer Therapy: A Comprehensive Review on Two‐Photon Photodynamic Therapy and Two‐Photon‐Activated Therapeutic Delivery Systems
Amir Soleimany, Delaram Kargari Aghmiouni, Masomeh Amirikhah, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 48
Closed Access | Times Cited: 10
Targeting tumor suppressor genes for cancer therapy
Yunhua Liu, Xiaoxiao Hu, Cecil Han, et al.
BioEssays (2015) Vol. 37, Iss. 12, pp. 1277-1286
Open Access | Times Cited: 85
In Vivo Genome Editing as a Therapeutic Approach
Beatrice Xuan Ho, Sharon Jia Hui Loh, Woon‐Khiong Chan, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2721-2721
Open Access | Times Cited: 72
Mesenchymal stem cells: A new platform for targeting suicide genes in cancer
Rana Moradian Tehrani, Javad Verdi, Mahdi Noureddini, et al.
Journal of Cellular Physiology (2017) Vol. 233, Iss. 5, pp. 3831-3845
Closed Access | Times Cited: 71
Folate-Targeted mRNA Delivery Using Chitosan-Functionalized Selenium Nanoparticles: Potential in Cancer Immunotherapy
Fiona Maiyo, Moganavelli Singh
Pharmaceuticals (2019) Vol. 12, Iss. 4, pp. 164-164
Open Access | Times Cited: 70
CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
Mohammadreza Azangou‐Khyavy, Mobina Ghasemi, Javad Khanali, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 65
Nanotechnology based therapeutic application in cancer diagnosis and therapy
Ragini Singh
3 Biotech (2019) Vol. 9, Iss. 11
Open Access | Times Cited: 59
Bacteria and cancer: Different sides of the same coin
Ghazaleh Laliani, Shokufeh Ghasemian Sorboni, Roya Lari, et al.
Life Sciences (2020) Vol. 246, pp. 117398-117398
Closed Access | Times Cited: 56
Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Hidayati Husainy Hasbullah, Marahaini Musa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11941-11941
Open Access | Times Cited: 54
Copper sulphide based heterogeneous nanoplatforms for multimodal therapy and imaging of cancer: Recent advances and toxicological perspectives
Ajinkya Nitin Nikam, Abhijeet Pandey, Gasper Fernandes, et al.
Coordination Chemistry Reviews (2020) Vol. 419, pp. 213356-213356
Closed Access | Times Cited: 52
Strategies for cancer gene-delivery improvement by non-viral vectors
María L. Santana‐Armas, Conchita Tros de Ilarduya
International Journal of Pharmaceutics (2021) Vol. 596, pp. 120291-120291
Open Access | Times Cited: 51
Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application
Md. Rizwanullah, Mohammad Zaki Ahmad, Anuj Garg, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 9, pp. 129936-129936
Closed Access | Times Cited: 43
Overcoming barriers in non-viral gene delivery for neurological applications
Aaron Tasset, Arjun Bellamkonda, Wenliang Wang, et al.
Nanoscale (2022) Vol. 14, Iss. 10, pp. 3698-3719
Open Access | Times Cited: 37
Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy
Haonan Li, Wenli Zang, Zhen Mi, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 256-275
Closed Access | Times Cited: 32
Quantum Dots as a Potential Multifunctional Material for the Enhancement of Clinical Diagnosis Strategies and Cancer Treatments
Wenqi Guo, Xueru Song, Jiaqi Liu, et al.
Nanomaterials (2024) Vol. 14, Iss. 13, pp. 1088-1088
Open Access | Times Cited: 7
Designing cytochrome P450 enzymes for use in cancer gene therapy
Saskya E. Carrera-Pacheco, Alexander Mueller, Juan A. Puente-Pineda, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 6
Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar, et al.
International Journal of Pharmaceutics (2019) Vol. 573, pp. 118729-118729
Closed Access | Times Cited: 51
The Horizon of Gene Therapy in Modern Medicine: Advances and Challenges
Babak Arjmand, Bagher Larijani, Motahareh Sheikh Hosseini, et al.
Advances in experimental medicine and biology (2019), pp. 33-64
Closed Access | Times Cited: 49
Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
Fabrizio Fontana, M. Raimondi, Monica Marzagalli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6806-6806
Open Access | Times Cited: 48
Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are
Foad Rommasi
Oncology and Therapy (2021) Vol. 10, Iss. 1, pp. 23-54
Open Access | Times Cited: 38
Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade
Alireza Shoari, Raheleh Tooyserkani, Mehdi Tahmasebi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1391-1391
Open Access | Times Cited: 37
Roles of MET in human cancer
Xin Yang, Hai-Yang Liao, Haihong Zhang
Clinica Chimica Acta (2021) Vol. 525, pp. 69-83
Closed Access | Times Cited: 35
A prospective strategy leveraging nanomedicine for cancer therapy: Pouring ferroptosis on apoptosis
Yutian Xia, Jianzhong Zhang, Gang Liu
Nano Today (2022) Vol. 48, pp. 101740-101740
Closed Access | Times Cited: 26
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health
Shivani Thoidingjam, Sushmitha Sriramulu, Svend O. Freytag, et al.
Translational Medicine Communications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 13

Scroll to top